RU2558042C2 - Высокочувствительный способ определения количества компонентов, полученных из лекарственных трав - Google Patents

Высокочувствительный способ определения количества компонентов, полученных из лекарственных трав Download PDF

Info

Publication number
RU2558042C2
RU2558042C2 RU2013125221/15A RU2013125221A RU2558042C2 RU 2558042 C2 RU2558042 C2 RU 2558042C2 RU 2013125221/15 A RU2013125221/15 A RU 2013125221/15A RU 2013125221 A RU2013125221 A RU 2013125221A RU 2558042 C2 RU2558042 C2 RU 2558042C2
Authority
RU
Russia
Prior art keywords
blood plasma
methanol
acid
solid phase
concentration
Prior art date
Application number
RU2013125221/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2013125221A (ru
Inventor
Каёко СУДЗУКИ
Цунехару СУДЗУКИ
Митико ЦУКАХАРА
Юко ХАРУТА
Акира ХАТТА
Юдзи ХАМАДА
Хидэо ИНОЭ
Original Assignee
Минофаген Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Минофаген Фармасьютикал Ко., Лтд. filed Critical Минофаген Фармасьютикал Ко., Лтд.
Publication of RU2013125221A publication Critical patent/RU2013125221A/ru
Application granted granted Critical
Publication of RU2558042C2 publication Critical patent/RU2558042C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
RU2013125221/15A 2010-11-16 2011-11-15 Высокочувствительный способ определения количества компонентов, полученных из лекарственных трав RU2558042C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010256187A JP5193266B2 (ja) 2010-11-16 2010-11-16 生薬由来成分の高感度定量方法
JP2010-256187 2010-11-16
PCT/JP2011/076248 WO2012067090A1 (ja) 2010-11-16 2011-11-15 生薬由来成分の高感度定量方法

Publications (2)

Publication Number Publication Date
RU2013125221A RU2013125221A (ru) 2014-12-10
RU2558042C2 true RU2558042C2 (ru) 2015-07-27

Family

ID=46084017

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013125221/15A RU2558042C2 (ru) 2010-11-16 2011-11-15 Высокочувствительный способ определения количества компонентов, полученных из лекарственных трав

Country Status (5)

Country Link
JP (1) JP5193266B2 (enExample)
KR (1) KR101476144B1 (enExample)
CN (1) CN103210308B (enExample)
RU (1) RU2558042C2 (enExample)
WO (1) WO2012067090A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2603363C1 (ru) * 2015-09-23 2016-11-27 федеральное государственное бюджетное образовательное учреждение высшего образования "Новосибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НГМУ Минздрава России) Вольтамперометрический способ количественного определения глицирризиновой кислоты в фармацевтических субстанциях
RU2700831C1 (ru) * 2019-01-24 2019-09-23 Федеральное государственное бюджетное учреждение "Научный центр экспертизы средств медицинского применения" Министерства здравоохранения Российской Федерации (ФГБУ "НЦЭСМП" Минздрава России) Способ количественного определения глицина в биологических лекарственных препаратах методом гидрофильной высокоэффективной жидкостной хроматографии

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115598231B (zh) * 2016-08-15 2025-11-18 豪夫迈·罗氏有限公司 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法
CN107064327A (zh) * 2016-12-23 2017-08-18 东北制药集团沈阳第制药有限公司 一种检测复方甘草片中吗啡和甘草酸含量的方法
JP7019372B2 (ja) * 2017-10-19 2022-02-15 株式会社あすか製薬メディカル ビタミンｄ代謝物の選択的測定法
JP7479633B2 (ja) 2020-12-03 2024-05-09 株式会社ツムラ アンバムの分析方法
CN113984916B (zh) * 2021-09-28 2024-04-19 天津中医药大学第一附属医院 一种正髓丸及正髓丸药材含量测定方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5325675B2 (enExample) * 1973-12-14 1978-07-28
JPS5251995A (en) * 1975-10-23 1977-04-26 Rooto Seiyaku Kk Method of analyzing clycyrrhizin
US20050148088A1 (en) * 2002-04-19 2005-07-07 Eng Shi Ong Pressurized hot water extraction
KR20040099885A (ko) * 2003-05-20 2004-12-02 한국과학기술연구원 가미자도환의 주요성분 동시 분석방법
BRPI0808416A2 (pt) * 2007-03-07 2014-07-22 Sanofi Aventis Us Llc Determinação quantitativa de risedronato na urina por spe-lc-ms-ms
CN101216465B (zh) * 2007-12-28 2011-01-12 北京联合大学生物化学工程学院 甘草药材指纹图谱的建立方法及其标准指纹图谱
CN101532994B (zh) * 2009-04-18 2013-02-27 姚俊华 健脑补肾制剂的含量测定方法
CN101897680A (zh) * 2009-06-01 2010-12-01 天津药物研究院 液体胶囊制剂、其制备方法及用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Sakamaki N. Et al. simultaneous determination of stevioside, rebaudioside A and glycyrrhizic acid in foods by HPLC. Перечень данных [он-лайн] fghtkm 2004 [Найдено 06.07.2014] " найдено из Интернет: URL: http://www.ncbi.nlm.nih.gov/pubmed/15272605. О.Б. РУДАКОВ и др. Физико-химические системы сорбат-сорбент-элюент в жидкостной хроматографии. - Воронеж, 2003. С.29-39. Руководство по методам контроля качества и безопастности биологически активных добавок к пище. - М.: Федеральный центр Госсанэпиднадзора Минздрава России, 2004. С.141-142 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2603363C1 (ru) * 2015-09-23 2016-11-27 федеральное государственное бюджетное образовательное учреждение высшего образования "Новосибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НГМУ Минздрава России) Вольтамперометрический способ количественного определения глицирризиновой кислоты в фармацевтических субстанциях
RU2700831C1 (ru) * 2019-01-24 2019-09-23 Федеральное государственное бюджетное учреждение "Научный центр экспертизы средств медицинского применения" Министерства здравоохранения Российской Федерации (ФГБУ "НЦЭСМП" Минздрава России) Способ количественного определения глицина в биологических лекарственных препаратах методом гидрофильной высокоэффективной жидкостной хроматографии

Also Published As

Publication number Publication date
WO2012067090A1 (ja) 2012-05-24
RU2013125221A (ru) 2014-12-10
KR20130076892A (ko) 2013-07-08
JP2012107954A (ja) 2012-06-07
KR101476144B1 (ko) 2014-12-24
CN103210308B (zh) 2015-01-07
JP5193266B2 (ja) 2013-05-08
CN103210308A (zh) 2013-07-17

Similar Documents

Publication Publication Date Title
JP7399214B2 (ja) 液体クロマトグラフィー質量分析による体液中のアミノ酸分析
Busardò et al. Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) for determination of GHB, precursors and metabolites in different specimens: application to clinical and forensic cases
ES3057168T3 (en) A method of processing a biological sample
Szerkus et al. Robust HPLC–MS/MS method for levofloxacin and ciprofloxacin determination in human prostate tissue
Klepacki et al. Amino acids in a targeted versus a non-targeted metabolomics LC-MS/MS assay. Are the results consistent?
Kubica et al. Modern approach for determination of lactulose, mannitol and sucrose in human urine using HPLC–MS/MS for the studies of intestinal and upper digestive tract permeability
Roda et al. Development and validation of a sensitive HPLC–ESI-MS/MS method for the direct determination of glucosamine in human plasma
KR101476144B1 (ko) 생약 유래 성분의 고감도 정량 방법
JP7753359B2 (ja) ヒト血漿中のリゼルギン酸ジエチルアミド（ｌｓｄ）及び２，３－ジヒドロ－３－ヒドロキシ－２－オキソリセルギド（ｏ－ｈ－ｌｓｄ）を定量化するための方法
Haas et al. Diagnosis and therapeutic monitoring of inborn errors of creatine metabolism and transport using liquid chromatography–tandem mass spectrometry in urine, plasma and CSF
Dai et al. Comparative pharmacokinetics of acteoside from total glycoside extracted from leaves of Rehmannia and Dihuangye total glycoside capsule in normal and diabetic nephropathy rats
Schleiff et al. An isocratic HPLC-UV analytical procedure for assessment of glutathione and its related substances
Park et al. Validated LC‐MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteers
Kim et al. Pharmacokinetics, tissue distribution, and tentative metabolite identification of sauchinone in mice by microsampling and HPLC-MS/MS methods
Jin et al. Simultaneous determination of multiple compounds of Da-Huang-Xiao-Shi decoction in rat plasma by LC-MS/MS and its application in a pharmacokinetic study
Wen et al. LC-MS/MS-based method for simultaneous quantification of known chemicals and metabolites of Alpiniae oxyphyllae Fructus extract in rat plasma and its application in a pharmacokinetic study
Sun et al. Ultra-performance liquid-chromatography with tandem mass spectrometry performing pharmacokinetic and biodistribution studies of croomine, neotuberostemonine and tuberostemonine alkaloids absorbed in the rat plasma after oral administration of Stemonae Radix
Pan et al. Simultaneous determination of forsythin and its major metabolites in human plasma via liquid chromatography-tandem mass spectrometry
Wu et al. Pharmacokinetics and tissue distribution of key sesquiterpene glycosides in Dendrobium nobile analyzed by UHPLC-Q-Trap-MS/MS
RU2705363C1 (ru) Способ определения лекарственного препарата метформин в смешанной слюне пациента, страдающего сахарным диабетом
Arafat et al. Determination of loperamide in human plasma and saliva by liquid chromatography–tandem mass spectrometry
Zhang et al. Quantitative analysis of biomarkers of liver and kidney injury in serum and urine using ultra‐fast liquid chromatography with tandem mass spectrometry coupled with a hydrophilic interaction chromatography column: Application to monitor injury induced by Euphorbiae pekinensis Radix
Park et al. Rapid quantification of levosulpiride in human plasma using RP‐HPLC‐MS/MS for pharmacokinetic and bioequivalence study
Zhang Dynamic Biodistribution of Icaritin and Its Phase-II Metabolite in Rat Tissues by Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry
Carter et al. Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations